258 related articles for article (PubMed ID: 15140998)
1. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid.
Hatziioannou T; Cowan S; Von Schwedler UK; Sundquist WI; Bieniasz PD
J Virol; 2004 Jun; 78(11):6005-12. PubMed ID: 15140998
[TBL] [Abstract][Full Text] [Related]
2. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
3. Influence of gag on human immunodeficiency virus type 1 species-specific tropism.
Ikeda Y; Ylinen LM; Kahar-Bador M; Towers GJ
J Virol; 2004 Nov; 78(21):11816-22. PubMed ID: 15479823
[TBL] [Abstract][Full Text] [Related]
4. Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
Sokolskaja E; Sayah DM; Luban J
J Virol; 2004 Dec; 78(23):12800-8. PubMed ID: 15542632
[TBL] [Abstract][Full Text] [Related]
5. Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection.
Sayah DM; Luban J
J Virol; 2004 Nov; 78(21):12066-70. PubMed ID: 15479848
[TBL] [Abstract][Full Text] [Related]
6. Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors.
Towers GJ; Hatziioannou T; Cowan S; Goff SP; Luban J; Bieniasz PD
Nat Med; 2003 Sep; 9(9):1138-43. PubMed ID: 12897779
[TBL] [Abstract][Full Text] [Related]
7. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
8. Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
Hatziioannou T; Perez-Caballero D; Cowan S; Bieniasz PD
J Virol; 2005 Jan; 79(1):176-83. PubMed ID: 15596813
[TBL] [Abstract][Full Text] [Related]
9. Restriction factors: a defense against retroviral infection.
Bieniasz PD
Trends Microbiol; 2003 Jun; 11(6):286-91. PubMed ID: 12823946
[TBL] [Abstract][Full Text] [Related]
10. Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.
Dodding MP; Bock M; Yap MW; Stoye JP
J Virol; 2005 Aug; 79(16):10571-7. PubMed ID: 16051849
[TBL] [Abstract][Full Text] [Related]
11. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
[TBL] [Abstract][Full Text] [Related]
12. Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.
Hatziioannou T; Cowan S; Bieniasz PD
J Virol; 2004 Jan; 78(2):1006-11. PubMed ID: 14694132
[TBL] [Abstract][Full Text] [Related]
13. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
[TBL] [Abstract][Full Text] [Related]
14. Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.
Lin TY; Emerman M
Virology; 2008 Sep; 379(2):335-41. PubMed ID: 18678385
[TBL] [Abstract][Full Text] [Related]
15. Functional analysis of the secondary HIV-1 capsid binding site in the host protein cyclophilin A.
Peng W; Shi J; Márquez CL; Lau D; Walsh J; Faysal KMR; Byeon CH; Byeon IL; Aiken C; Böcking T
Retrovirology; 2019 Apr; 16(1):10. PubMed ID: 30947724
[TBL] [Abstract][Full Text] [Related]
16. Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.
Berthoux L; Sebastian S; Sokolskaja E; Luban J
J Virol; 2004 Nov; 78(21):11739-50. PubMed ID: 15479815
[TBL] [Abstract][Full Text] [Related]
17. Dynamic allostery governs cyclophilin A-HIV capsid interplay.
Lu M; Hou G; Zhang H; Suiter CL; Ahn J; Byeon IJ; Perilla JR; Langmead CJ; Hung I; Gor'kov PL; Gan Z; Brey W; Aiken C; Zhang P; Schulten K; Gronenborn AM; Polenova T
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14617-22. PubMed ID: 26553990
[TBL] [Abstract][Full Text] [Related]
18. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
Fischer DK; Saito A; Kline C; Cohen R; Watkins SC; Yamashita M; Ambrose Z
J Virol; 2019 May; 93(9):. PubMed ID: 30814280
[TBL] [Abstract][Full Text] [Related]
19. Assisted evolution enables HIV-1 to overcome a high TRIM5α-imposed genetic barrier to rhesus macaque tropism.
Soll SJ; Wilson SJ; Kutluay SB; Hatziioannou T; Bieniasz PD
PLoS Pathog; 2013; 9(9):e1003667. PubMed ID: 24086139
[TBL] [Abstract][Full Text] [Related]
20. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
